Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

The recent identification of “side population” (SP) cells in a number of unrelated human cancers and their normal tissue sources has renewed interest in the hypothesis that cancers may arise from somatic stem/progenitor cells. The high incidence of recurrence attributable to multidrug resistance and the multiple histologic phenotypes indicative of multipotency suggests a stem cell-like etiology of ovarian cancer. Here we identify and characterize SP cells from two distinct genetically engineered mouse ovarian cancer cell lines. Differential efflux of the DNA-binding dye Hoechst 33342 from these cell lines defined a human breast cancer-resistance protein 1-expressing, verapamil-sensitive SP of candidate cancer stem cells.In vivo, mouse SP cells formed measurable tumors sooner than non-SP (NSP) cells when equal numbers were injected into the dorsal fat pad of nude mice. The presence of Mullerian Inhibiting Substance (MIS) signaling pathway transduction molecules in both SP and NSP mouse cells led us to investigate the efficacy of MIS against these populations in comparison with traditional chemotherapies. MIS inhibited the proliferation of both SP and NSP cells, whereas the lipophilic chemotherapeutic agent doxorubicin more significantly inhibited the NSP cells. Finally, we identified breast cancer-resistance protein 1-expressing verapamil-sensitive SPs in three of four human ovarian cancer cell lines and four of six patient primary ascites cells. In the future, individualized therapy must incorporate analysis of the stem cell-like subpopulation of ovarian cancer cells when designing therapeutic strategies for ovarian cancer patients.

Bibliography

Szotek, P. P., Pieretti-Vanmarcke, R., Masiakos, P. T., Dinulescu, D. M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., MacLaughlin, D. T., & Donahoe, P. K. (2006). Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proceedings of the National Academy of Sciences, 103(30), 11154–11159.

Authors 10
  1. Paul P. Szotek (first)
  2. Rafael Pieretti-Vanmarcke (additional)
  3. Peter T. Masiakos (additional)
  4. Daniela M. Dinulescu (additional)
  5. Denise Connolly (additional)
  6. Rosemary Foster (additional)
  7. David Dombkowski (additional)
  8. Frederic Preffer (additional)
  9. David T. MacLaughlin (additional)
  10. Patricia K. Donahoe (additional)
References 42 Referenced 580
  1. 10.1073/pnas.0530291100
  2. 10.1634/stemcells.2005-0282
  3. 10.1073/pnas.0307618100
  4. 10.1182/blood.V98.4.1166
  5. G. M. Seigel, L. M. Campbell, M. Narayan, F. Gonzalez-Fernandez Mol. Vis. 11, 729–737 (2005). / Mol. Vis. by Seigel G. M. (2005)
  6. G. Poste, R. Greig Invasion Metastasis 2, 137–176 (1982). / Invasion Metastasis by Poste G. (1982)
  7. 10.1073/pnas.79.21.6574
  8. 10.1038/35102167
  9. 10.1016/S1470-2045(02)00820-3
  10. 10.1146/annurev.cellbio.21.012704.131525
  11. 10.1186/1477-7827-2-20
  12. 10.1016/S0046-8177(70)80005-3
  13. 10.1038/modpathol.3800305
  14. 10.3322/canjclin.55.1.10
  15. 10.1056/NEJM199311183292108
  16. 10.3322/canjclin.47.1.5
  17. 10.1038/nrc706
  18. 10.1084/jem.183.4.1797
  19. D. C. Connolly, R. Bao, A. Y. Nikitin, K. C. Stephens, T. W. Poole, X. Hua, S. S. Harris, B. C. Vanderhyden, T. C. Hamilton Cancer Res. 63, 1389–1397 (2003). / Cancer Res. by Connolly D. C. (2003)
  20. 10.1038/nm1173
  21. 10.1073/pnas.0400067101
  22. 10.1038/sj.onc.1206938
  23. 10.1146/annurev.bi.62.070193.002125
  24. 10.1016/j.critrevonc.2004.04.007
  25. 10.1158/1078-0432.CCR-05-2108
  26. 10.1242/dev.02383
  27. 10.1093/carcin/bgh293
  28. R. P. Gale, A. Butturini Leukemia 6, 80–85 (1992). / Leukemia by Gale R. P. (1992)
  29. 10.1111/j.1749-6632.1956.tb50894.x
  30. Z. Duan, K. A. Brakora, M. V. Seiden Mol. Cancer Ther. 3, 833–838 (2004). (10.1158/1535-7163.833.3.7) / Mol. Cancer Ther. by Duan Z. (2004)
  31. Z. Duan, D. E. Lamendola, R. Z. Yusuf, R. T. Penson, F. I. Preffer, M. V. Seiden Anticancer Res. 22, 1933–1941 (2002). / Anticancer Res. by Duan Z. (2002)
  32. 10.1016/j.ygyno.2003.11.053
  33. 10.1006/gyno.2002.6762
  34. 10.1016/0090-8258(85)90019-8
  35. 10.1074/jbc.M005701200
  36. 10.1634/stemcells.20-5-417
  37. 10.1002/ijc.2910450306
  38. 10.1016/0022-1759(86)90368-6
  39. H. K. Lorenzo, J. Teixeira, N. Pahlavan, V. M. Laurich, P. K. Donahoe, D. T. MacLaughlin J. Chromatogr. B Biomed. Sci. Appl. 766, 89–98 (2002). / J. Chromatogr. B Biomed. Sci. Appl. by Lorenzo H. K. (2002)
  40. 10.1210/jcem-70-1-16
  41. 10.1095/biolreprod15.3.329
  42. 10.1016/0022-4804(77)90202-5
Dates
Type When
Created 19 years, 1 month ago (July 18, 2006, 8:35 p.m.)
Deposited 2 years, 3 months ago (May 8, 2023, 12:11 a.m.)
Indexed 10 hours, 52 minutes ago (Sept. 3, 2025, 6:48 a.m.)
Issued 19 years, 1 month ago (July 25, 2006)
Published 19 years, 1 month ago (July 25, 2006)
Published Online 19 years, 1 month ago (July 25, 2006)
Published Print 19 years, 1 month ago (July 25, 2006)
Funders 0

None

@article{Szotek_2006, title={Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness}, volume={103}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0603672103}, DOI={10.1073/pnas.0603672103}, number={30}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Szotek, Paul P. and Pieretti-Vanmarcke, Rafael and Masiakos, Peter T. and Dinulescu, Daniela M. and Connolly, Denise and Foster, Rosemary and Dombkowski, David and Preffer, Frederic and MacLaughlin, David T. and Donahoe, Patricia K.}, year={2006}, month=jul, pages={11154–11159} }